GE HealthCare (GEHC) Reports Q1 Earnings: What Key Metrics Have to Say

GE HealthCare Technologies (GEHC) reported $5.13 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 7.4%. EPS of $0.99 for the same period compares to $1.01 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $5.05 billion, representing a surprise of +1.52%. The company delivered an EPS surprise of -7.04%, with the consensus EPS estimate being $1.07.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how GE HealthCare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenues- Imaging: $2.3 billion versus the three-analyst average estimate of $2.25 billion. The reported number represents a year-over-year change of +7.4%.Revenues- AVS (Advanced Visualization Solutions): $1.34 billion versus $1.3 billion estimated by three analysts on average.Revenues- Other: $18 million versus the three-analyst average estimate of $12.71 million. The reported number represents a year-over-year change of +38.5%.Revenues- PDx (Pharmaceutical Diagnostics): $770 million versus $735.21 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +21.8% change.Revenues- PCS (Patient Care Solutions): $704 million versus the three-analyst average estimate of $770.88 million. The reported number represents a year-over-year change of -6.5%.Segment EBIT- Imaging: $180 million versus the two-analyst average estimate of $198.22 million.Segment EBIT- PDx: $197 million versus $221.25 million estimated by two analysts on average.Segment EBIT- PCS: $10 million compared to the $50.02 million average estimate based on two analysts.Segment EBIT- AVS: $299 million versus the two-analyst average estimate of $267.18 million.View all Key Company Metrics for GE HealthCare here>>>Shares of GE HealthCare have returned -3.8% over the past month versus the Zacks S&P 500 composite's +12.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks